Investors

Overview

Corporate Presentation

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

For Investors:

Mark Mullikin
Editas Medicine, Inc.
Phone: 617.401.9083
E-mail: mark.mullikin@editasmed.com

For Media:

Cristi Barnett
Editas Medicine, Inc.
Phone: 617.401.0133
E-mail: cristi.barnett@editasmed.com